Insilico Medicine
What They Do[edit]
AI-driven drug discovery company using deep learning for target identification, molecule generation, and clinical trial optimization. One of the most established AI pharma companies globally.
Activity (April 2026)[edit]
Hosted "Pharma AI Spring Kickoff 2026" webinar on AI drug discovery applications.[1] CEO discussed practical AI applications in pharma R&D, emphasizing real results over hype.[2]
Funding[edit]
Valuation: Est. $1B+ (AI drug discovery leader)